Martek/Kellogg agreement
This article was originally published in The Tan Sheet
Executive Summary
Columbia, Md.-based firm announces a 15-year, non-exclusive docosahexaenoic acid (DHA) license and supply agreement with Kellogg Feb. 4, with the first DHA-fortified food product scheduled for launch in mid-2006. Kellogg will develop foods containing Martek's DHA and "must purchase, subject to certain exceptions, almost all of its DHA from Martek" for products in the U.S., as well as "display the Martek DHA logo on all product packages, print advertisements and certain other promotional materials." Martek has supply agreements with Mead Johnson and Nestle to provide DHA for infant formula...
You may also be interested in...
Martek DHA Gets Consumer-Friendly For Upcoming Functional Food Launches
A DHA-enriched Kellogg product may be the first functional food to launch with Martek's new life'sDHA brand name and logo on its label, according to a Sept. 6 analysts call
Martek S&P MidCap
Columbia, Md.-based firm will be added to Standard & Poor's MidCap 400 index after the close of trading March 1, Martek announces Feb. 25; the index covers roughly 7% of the U.S. equities market. CEO Henry Linsert says Martek's addition "should broaden the company's exposure to investors." Martek signed a license and supply agreement with Kellogg earlier this month (1"The Tan Sheet" Feb. 14, 2005, In Brief)...
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.